Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

Investegate

May 25, 2020

Abivax announces German regulatory approval of ABX464 Covid-19 Phase 2b/3 COVID-19 clinical trial

BFM Bourse -TradingSat

May 25, 2020

ABIVAX : FEU VERT ALLEMAND POUR UNE ÉTUDE DANS LE COVID-19

GoingPublic

May 25, 2020

Abivax erhält Genehmigung für klinische COVID-19-Studie in Deutschland

Der Aktionär

May 25, 2020

Moderna, CanSino Biologics, Abivax, Shop Apotheke Europe und Dermapharm: So geht es jetzt weiter!

4 investors

May 25, 2020

Abivax: Evotec-Partner will Covid-19-Medikamentenstudie noch im Mai starten

  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn